An app for depression after breast cancer

313 women were enrolled in a trial of a fully automated, publicly available program — because there aren't enough therapists.

Depression and anxiety are common after breast cancer, but there aren’t nearly enough therapists to go around, which is why this trial tested a fully automated, publicly available app-based program. Researchers enrolled 313 women within five years of a breast cancer diagnosis who had elevated depression or anxiety, and randomly assigned them (2:1) to either an 8-week digital mental health program (a suite of five clinically focused apps called IntelliCare) or a patient-education app that served as an active comparison. Both groups improved meaningfully over time, but the digital program had an edge specifically for anxiety, producing significantly greater reductions than the education app. For depression, the digital program’s advantage did not reach statistical significance. The trial also tested whether adding a human coach helped people who barely used the app in week one; coaching did boost how many days they engaged. The bottom line: a scalable, self-guided app can help breast cancer survivors, particularly with anxiety, and a light touch of human support can keep less-engaged users coming back. It won’t replace therapy for everyone, but it can extend real help to survivors who otherwise couldn’t access care.